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background: Despite the accumulating genetic and molecular research into hypertrophic cardiomyopathy (HCM), it remains unclear how HCM 
develops and worsens pathologically and clinically in terms of the genetic-environmental interactions. Thus, establishing human disease models for 
HCM would help us to investigate the disease mechanisms and novel therapeutic strategies. Patient-specific induced pluripotent stem cells (iPSC) 
hold much promise for these tasks.
Methods: We hypothesized there were etiological interactions between genetic backgrounds and environmental factors involved in the progression 
of HCM. To clarify candidate disease-promoting environmental factors, iPSCs from unrelated three patients with HCM and three healthy-control 
subjects were generated. The cardiomyocytes differentiated from the each iPSC line were stimulated by several cardiomyocyte hypertrophy-promoting 
factors. The HCM pathological phenotypes were examined based on the morphological properties, such as cell size and intracellular myofibril 
structures. Next, a high-speed video imaging with motion vector prediction algorithm revealed physiological contractile dynamics in the iPSC-derived 
singled cardiomyocytes.
results: Control- and HCM-iPSC-derived cardiomyocytes were similar under the basal condition in pathological features and contractile dynamics. 
However, only the HCM-iPSC-derived cardiomyocytes showed pathological phenotypes, such as cardiomyocyte hypertrophy and facilitated 
intracellular myofibril disorganization in the presence of endothelin-1 (ET-1) administration, followed by specific activation of the calcineurin-nuclear 
factor of activated T-cells pathway. Moreover, physiological analyses revealed ET-1-induced contractile dispersion in the self-beating HCM-iPSC-
derived cardiomyocytes. Finally, these deleterious effects were rescued by blocking the endothelin receptor type-A.
conclusions: Interactions between genetic backgrounds and the environmental factor, ET-1, promoted the pathophysiological phenotypes in the 
HCM-iPSC-derived cardiomyocytes.
